Chronobiotic activity of N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]-propanamide. Synthesis and melatonergic pharmacology of fluoren-9-ylethyl amides

Add time:07/11/2019    Source:sciencedirect.com

A series of fluoren-9-yl ethyl amides (2) were synthesized and evaluated for human melatonin MT1 and MT2 receptor binding. N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]propanamide (2b) was selected and evaluated in functional assays measuring intrinsic activity at the human MT1 and MT2 receptors and demonstrated full agonism at both receptors. The chronobiotic properties of 2b were demonstrated in both acute and chronic rat models where 2b produced an acute phase advance of 32 min at 1 mg/kg and chronically entrained free-running rats with a mean effective dose of 0.23 mg/kg. Compound 2b is significantly less efficacious than melatonin in constricting human coronary artery.

We also recommend Trading Suppliers and Manufacturers of Propanamide, 2,2-diethoxy- (cas 92845-55-1). Pls Click Website Link as below: cas 92845-55-1 suppliers

Prev:Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo
Next:Reactions of low-energy pentenyl methyl ether radical cations C2H5CHCHCH2OCH3+, CH2CHCH(C2H5)OCH3+ and CH2C(C2H5)CH2OCH3+)